Stay updated on KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check23 days agoChange DetectedA site-wide notice says NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.8%

- Check30 days agoChange DetectedThe footer’s ClinicalTrials.gov software revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check37 days agoChange DetectedThe site’s displayed revision changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check58 days agoChange DetectedThe history now records a new system revision: v3.7.0. The previous revision, v3.6.6, is removed from the history.SummaryDifference0.1%

- Check79 days agoChange DetectedThe record history now shows the latest revision as v3.6.6, replacing the prior v3.6.5 entry. This indicates a new version has been saved in the study's history.SummaryDifference0.1%

Stay in the know with updates to KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page.